13:11 24/10/2014 Sizzling Stock Alert: Novavax, Inc. (NVAX), Arena Pharmaceuticals, Inc.(ARNA ...
Sizzling Stock Alert: Novavax, Inc. (NVAX), Arena Pharmaceuticals, Inc.(ARNA ...
Techsonian (press release) - 15 hours ago
Manhattan, NY- October 24, 2014 - (Techsonian) - Novavax, Inc. (NASDAQ:NVAX)revealed that Gregory Glenn, M.D., Senior Vice President, Research and Development at Novavax will present new immunogenicity data from Novavax' RSV F-Protein ...

15:48 22/10/2014 Hot Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Sunesis ...
Hot Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Sunesis ...
Market News Call - Oct 22, 2014
Eisai Inc. and Arena Pharmaceuticals, Inc. (ARNA) announced that data from the Phase 3 clinical trial program for BELVIQ (lorcaserin HCl) CIV was scheduled to be presented at the American College of Clinical Pharmacy (ACCP) Annual Meeting taking place ...
Stocks Trending Alert-CEL-SCI (NYSEMKT:CVM), Arena Pharmaceuticals ... - Techsonian (press release)

14:18 22/10/2014 Arena Investors Need To Watch Contrave Launch Closely
Arena Investors Need To Watch Contrave Launch Closely
Seeking Alpha (registration) - Oct 22, 2014
Arena Pharmaceuticals (NASDAQ:ARNA) investors now have something else to pay attention to. Orexigen ... Eisai may need to at some point, but I expect the company to be conservative and to collect some data before jumping to a rash conclusion.

13:20 22/10/2014 Could Arena Pharmaceuticals Inc. Be Running Out of Money?
Could Arena Pharmaceuticals Inc. Be Running Out of Money?
Motley Fool - Oct 22, 2014
With Wall Street not expecting the company to be profitable on annual basis until 2017, it's worth digging beyond the surface to discover whether or not Arena Pharmaceuticals could be running out of money. Today we'll do just that, as well as look at ...

14:52 20/10/2014 4 High-Gross Margin Stocks: Arena Pharmaceuticals, Inc. (ARNA), Gastar ...
4 High-Gross Margin Stocks: Arena Pharmaceuticals, Inc. (ARNA), Gastar ...
Investor Wired (press release) - Oct 20, 2014
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has return on equity ratio of -54.10%. The company has $881.56 million in market worth.

14:23 20/10/2014 Hot Biotech Round Up: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Hot Biotech Round Up: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
StreetWise Report - Oct 20, 2014
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declared that facts from the stage 3 scientific test program for BELVIQ (lorcaserin HCl) CIV will be launched at the American College of Clinical Pharmacy (ACCP) yearly conference held on last ...
Investor's Alert: Arena Pharmaceuticals, Inc. (ARNA), FuelCell Energy Inc ... - Techsonian (press release)

14:31 17/10/2014 Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA ...
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA ...
PR Newswire (press release) - Oct 17, 2014
Investor-Edge has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (NASDAQ: ARNA), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), XOMA Corporation (NASDAQ: XOMA), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA), and ...

14:47 15/10/2014 Pfizer Setback Could Help Arena
Pfizer Setback Could Help Arena
Seeking Alpha (registration) - Oct 15, 2014
It was only a month ago that the company received positive indications from the FDA when the regulators agreed to a new label for the drug that was less stringent than the earlier label.

15:43 13/10/2014 Pharma Stocks to Watch: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Pharma Stocks to Watch: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Street Newswire (registration) - Oct 13, 2014
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Monday said data from phase 3 clinical trials of its obesity drug BELVIQ (lorcaserin HCl) will be presented at the American College of Clinical Pharmacy meeting taking place through Wednesday of this week.

23:41 03/10/2014 Belviq Sales Flat - Model Your Expectations (ARNA)
Belviq Sales Flat - Model Your Expectations (ARNA)
Seeking Alpha (registration) - Oct 3, 2014
Sales of Arena Pharmaceuticals' (NASDAQ:ARNA) Belviq were essentially flat this week vs. last week, according to industry tracker IMS Health (NYSE:IMS).